Mpox (Affenpocken)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 370.64 billion USD, with a 24h change of +1.90%. Among 5 constituents, 4 are up (80.00%) and 1 are down (20.00%). The top gainer is GeoVax Labs, Inc. New (GOVX), with a 24h increase of +3.72%.Modest rebound with weak breadth and narrow leadership. Near term, follow liquid leaders; longer term, prioritize clinical/regulatory milestones, balance-sheet strength, and rate sensitivity.
Name
Letzter Preis
Änderung %
Letzter Preis / Änderung %
Chart
Price Range
Aktion
ABT
ABTAbbott Laboratories
105,29$105,29
+2,12 %+$2,19
105,29
+2,12 %
$103,06$105,72
GILD
GILDGilead Sciences Inc
131,68$131,68
+1,81 %+$2,35
131,68
+1,81 %
$129,33$132,51
DGX
DGXQuest Diagnostics Inc.
230,96$230,96
+1,36 %+$3,10
230,96
+1,36 %
$227,86$231,27
CODX
CODXCo-Diagnostics, Inc.
2,05$2,05
-2,38 %-$0,05
2,05
-2,38 %
$1,97$2,13
GOVX
GOVXGeoVax Labs, Inc. New
0,76$0,76
+3,72 %+$0,03
0,76
+3,72 %
$0,70$0,79